1994
DOI: 10.1016/0092-8674(94)90322-0
|View full text |Cite
|
Sign up to set email alerts
|

Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
715
2
9

Year Published

1996
1996
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 1,128 publications
(734 citation statements)
references
References 47 publications
7
715
2
9
Order By: Relevance
“…Full length TEL/PDGFRb cDNA inserted into the pSRa/ MSV/TK/neo retroviral expressing vector was described previously (Golub et al, 1994). The dominant-interfering mutants pcDNA3-FLAG-MKK4 Ala, pCEV29N19RhoA, pCEV29N17Rac1, pCEV29N17Cdc42H, and pCMV5-MEKK (K432A) have also been described .…”
Section: Vectorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Full length TEL/PDGFRb cDNA inserted into the pSRa/ MSV/TK/neo retroviral expressing vector was described previously (Golub et al, 1994). The dominant-interfering mutants pcDNA3-FLAG-MKK4 Ala, pCEV29N19RhoA, pCEV29N17Rac1, pCEV29N17Cdc42H, and pCMV5-MEKK (K432A) have also been described .…”
Section: Vectorsmentioning
confidence: 99%
“…The TEL/PDGFRb (T/P) is a chimeric oncogene formed by the chromosomal translocation t(5;12) that fuses the amino terminus of TEL to the transmembrane and cytoplasmic domains of the platelet-derived growth factor receptor b (PDGFRb) (Golub et al, 1994). The self-association of T/P mediated by the helix ± loop ± helix (HLH) domain of TEL leads to constitutive activation of the PDGFRb tyrosine kinase and stimulation of PDGFRb-dependent signalling pathways (Carroll et al, 1996;Jousset et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…The TEL gene, located at chromosomal band 12p13, was ®rst isolated during the study of the t(5;12)(q33;p13) translocation (Golub et al, 1994). Since then, it has been shown to be involved in a variety of translocations seen in human hematopoietic malignancies Golub et al, 1996b).…”
Section: Introductionmentioning
confidence: 99%
“…Most of them result in transcription of fusion genes between TEL and a partner gene on the other chromosome. Strikingly, partner genes encode di erent sorts of proteins, such as transcription factors (AML1, MN1, EVI-1) (Buijs et al, 1995;Golub et al, 1995;Peeters et al, 1997a;Romana et al, 1995a) or protein kinases (PDGFRb, ABL, JAK2), (Golub et al, 1994;Lacronique et al, 1997;Papadopoulos et al, 1995;Peeters et al, 1997b). In addition, the breakpoints of the di erent translocations within TEL are not clustered, further underscoring the di erential involvement of TEL in the leukemogenic process.…”
Section: Introductionmentioning
confidence: 99%
“…46 TEL-PDGFR␤ can confer cytokine independent growth to Ba/F3 cells. 47 Imatinib mesylate inhibits the kinase PDGFR␤ and is effective therapy in patients with this translocation.…”
Section: Constitutively Active Kinases As Targets Of Therapymentioning
confidence: 99%